Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.
about
Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesisTelomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.Epstein-Barr virus-induced up-regulation of TCAB1 is involved in the DNA damage response in nasopharyngeal carcinoma.DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomasEBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway.Epstein-Barr virus and telomerase: from cell immortalization to therapy.Therapeutic potential of siRNA and DNAzymes in cancer.Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarctionExtra-telomeric functions of telomerase in the pathogenesis of Epstein-Barr virus-driven B-cell malignancies and potential therapeutic implications.Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity
P2860
Q28077209-80DCB0EF-C787-4679-BD75-2155B6F1C36BQ30248577-1E728601-0F84-4BC5-9619-E2A5CA31FF4DQ33789662-D83012BC-35D4-42B0-9E65-50D7802D2C72Q34582022-BF879209-9012-4E11-8766-966F66B0ED6AQ35742407-DF0BDCF5-A950-47AB-B147-FEF75938B770Q36348567-2143A888-507D-4C58-970A-421AEFA30F4AQ37619108-3DEB780F-4524-4757-AC9E-9F705E4E1E6FQ38242397-6FCA63BB-9F0A-427A-ACE2-60E8DAE53224Q38568602-1BF10C4A-B5F3-4A6D-8BEF-AA37F713C303Q39344275-EE31A1E8-FD58-40A3-97B6-C57107B8D9A8Q41468713-F7A75A61-78D1-46D3-94BD-A4543FDF8E40Q52719942-CDB0E7C8-DF98-4649-BA3D-FACAE2064675Q58579018-91FCA5A7-F09B-4568-9834-F69464F92AE6
P2860
Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting EBV-LMP1 DNAzyme enh ...... nhibiting telomerase activity.
@en
Targeting EBV-LMP1 DNAzyme enh ...... nhibiting telomerase activity.
@nl
type
label
Targeting EBV-LMP1 DNAzyme enh ...... nhibiting telomerase activity.
@en
Targeting EBV-LMP1 DNAzyme enh ...... nhibiting telomerase activity.
@nl
prefLabel
Targeting EBV-LMP1 DNAzyme enh ...... nhibiting telomerase activity.
@en
Targeting EBV-LMP1 DNAzyme enh ...... nhibiting telomerase activity.
@nl
P2093
P2860
P356
P1476
Targeting EBV-LMP1 DNAzyme enh ...... nhibiting telomerase activity.
@en
P2093
Jingchen Lu
Lifang Yang
Lunquan Sun
Xiangjian Luo
P2860
P356
10.4161/CBT.26606
P577
2013-10-21T00:00:00Z